EFDID: 532728EFD: View Filing

Issuer: Summit Therapeutics Inc. (0001599298) - D

Accession: 0001599298-24-000142 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001599298
  • Entity Name:
    Summit Therapeutics Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2020)
  • Address:
    601 Brickell Key Drive
    SUITE 1000
    Miami, FL 33131
  • Persons:
    Related Persons 9
    Robert Duggan
    Executive Officer, Director
    Mahkam Zanganeh
    Executive Officer, Director
    Manmeet Soni
    Executive Officer, Director
    Kenneth Clark
    Director
    Robert Booth
    Director
    Alessandra Cesano
    Director
    Yu Xia
    Director
    Mostafa Ronaghi
    Director
    Jeff Huber
    Director
EDGAR: Offering Information
  • Accession Date:
    09/25/2024
  • First Sale Date:
    09/11/2024
  • Offering Amount:
    $234,999,889
  • Amount Sold:
    $234,999,889
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, MD, NY, PA, TX
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Summit Therapeutics Inc.Manmeet SoniManmeet SoniChief Financial Officer2024-09-25